NEUROONE MED TECHNOLOGIES CO's ticker is NMTC and the CUSIP is 64130M209. A total of 19 filers reported holding NEUROONE MED TECHNOLOGIES CO in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $47,599 | -23.1% | 59,499 | +15.3% | 0.00% | – |
Q1 2024 | $61,919 | -24.0% | 51,599 | 0.0% | 0.00% | – |
Q4 2023 | $81,526 | +77.4% | 51,599 | 0.0% | 0.00% | – |
Q3 2023 | $45,944 | +6.7% | 51,599 | +43.7% | 0.00% | – |
Q2 2023 | $43,079 | -25.5% | 35,899 | 0.0% | 0.00% | – |
Q1 2023 | $57,797 | -32.9% | 35,899 | -50.0% | 0.00% | – |
Q4 2022 | $86,158 | +41.2% | 71,798 | +100.0% | 0.00% | – |
Q3 2022 | $61,000 | – | 35,899 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mayo Clinic | 181,754 | $218,105 | 0.12% |
DRIVE WEALTH MANAGEMENT, LLC | 64,203 | $77,044 | 0.04% |
Virtu Financial LLC | 14,939 | $18 | 0.00% |
MAI Capital Management | 50,000 | $60,000 | 0.00% |
OSAIC HOLDINGS, INC. | 350 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 114,249 | $137 | 0.00% |
Citadel Advisors | 7,300 | $8,760 | 0.00% |
Citadel Advisors | 100 | $120 | 0.00% |
Citadel Advisors | 36,098 | $43,318 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 85,926 | $103,111 | 0.00% |